CClinicalTrials.gg
RecruitingNCT04699201PHITUpdated Oct 2, 2024

Trocar Site Incisional Hernia Prevention

An interventional study of Hincisional hernia prevention by onlay prosthesis trocar closure and laparoscopic cholecystectomy in Incisional Hernia, sponsored by Hospital Universitari Joan XXIII de Tarragona.. Recruiting at 2 sites in Spain. Open to participants aged 18 Years to 99 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-10-02.

Sponsored by Hospital Universitari Joan XXIII de Tarragona. · Not applicable, Interventional, and Prevention

From the registry’s dates

  • Primary completion was expected by Nov 2024, 1 year 11 months ago, but the record still lists the study as recruiting.
  • Started Mar 2021; still recruiting 5 years 7 months later.
Phase
Not applicable
Study type
Interventional
Enrollment
94
Allocation
Randomized
Ages
18 Years to 99 Years
Sex
All
01

Study summary

Objective: To test the preventive effect of the placement of an onlay mesh versus the use of a fascial closure device at the umbilical trocar site closure in order to prevent incisional hernia after laparoscopic surgery.

Methods: We designed a Two Center Randomized Controlled Trial were adult participants presenting for elective laparoscopic cholecystectomy, with or without an exploration of the common bile duct will be recruited, with allocation of each of them in 2 groups (prosthesis and control). Abdominal ultrasound scan focused on aponeurosis defects at the trocar sites will be performed at 12 postoperative months.

An ultrasound scan will be performed to avoid underdiagnosis bias since incisional hernia is frequently under detected by clinical examination.

Relevance: The prevalence of incisional hernia after laparoscopy might be as high as 30%, due to this reason is paramount to find a better closure technique.

There are few studies about incisional hernia including radiological exams in order to provide the exact prevalence of this pathology, even fewer literature exists about incisional hernia after laparoscopic procedures.

Read the detailed description

OBJECTIVE To test the preventive effect of the placement of an onlay mesh at the time of umbilical trocar site closure in order to prevent incisional hernia after laparoscopic surgery.

The estimated prevalence of incisional hernia after laparoscopy is 15- 25%, being even higher among patients with risk factors. Many different closure techniques exist, however few of them have been tested in Randomised Control Trials. Most of them lack an image technique to provide more accurate results.

METHODOLOGY

We designed a Two Center, Randomized Controlled Trial that will enroll patients undergoing laparoscopic cholecystectomy, with or without an exploration of the common bile duct. Participants will be randomized to 2 groups. The pneumoperitoneum technique will be achieved by Hasson technique. The closure procedure will take place at the end of the surgery, after the cholecystectomy is performed:

  • Prosthesis: after suturing the aponeurosis with a J needle and 0 Polydioxanone, a lightweight, large-pore mesh made of PVDF monofilament (polyvinylidene fluoride - DynaMesh-CICAT, FEC Textiltechnik, Germany) will be placed onlay, overlapping 2cm in all directions from the edge of the aponeurosis incision at the umbilical trocar site. The mesh will be fixed to the aponeurosis with cyanoacrylate glue (Glubran®, GEM, Viareggio, Italy).
  • Control: Closure of the aponeurosis will be performed by standard procedure: under direct vision, suturing the aponeurosis with a J needle and 0 Polydioxanone, with a stitch interval of ≤ 5mm.

An abdominal ultrasound scan focused on aponeurosis defects at the trocar sites will be performed at 12 postoperative months. Minimum follow-up will be 12 months.

All the adverse events will be registered and classified according to the Clavien Dindo classification.

An ultrasound scan will be performed to avoid underdiagnosis bias since incisional hernia is frequently under detected by clinical examination.

Relevance: The prevalence of incisional hernia after laparoscopy might be as high as 30%, due to this reason is paramount to find a better closure technique.

There are few studies about incisional hernia including radiological exams in order to provide the exact prevalence of this pathology, even fewer literature exists about incisional hernia after laparoscopic procedures.

Univariate descriptive analysis will present the results as means (with standard deviation and range) for the continuous variables and as numbers and percentages for the categorical variables. Bivariate analysis will be carried out among the variables of interest to describe their level of correlation and evaluate the possible differences between them. To evaluate the differences between the continuous variables we will use the comparison of means based on the T-Student and for the comparison of categorical variables the Chi-square test. Finally, linear regression models and generalized linear models (as appropriate depending on the response variable) will be used to study the dependence of the variables of interest, with other factors of study. Statistical analysis will be carried out using the SPSS (Statistical Package for the Social Sciences) Software (IBM SPSS Statistics 23). All tests will be bilateral with a level of significance of 5%. 100% of the data recorded will be analyzed, and the proportion of values lost in the variables of interest will be evaluated.

02

Conditions studied

  • Incisional Hernia

Keywords

  • Incisional Hernia, Umbilical Trocar, Preventive mesh
03

In context

Hernia

1,096 studies on the registry are indexed under Hernia; 132 are open to participants now.

This study's planned enrollment of 94 is above the median of 80 across 739 interventional studies indexed under Hernia.

Browse Hernia studies →

Lead sponsor

Hospital Universitari Joan XXIII de Tarragona. is the lead sponsor of 7 studies on the registry; 1 is open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 99 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  • Patients undergoing elective laparoscopic cholecystectomy, with or without an exploration of the common bile duct, undergoing surgery in our hospital
  • ASA (American Society of Anesthesiologists) \<IV

Exclusion criteria

Exclusion Criteria:

  • Allergy or intolerance to any of the mesh components
  • Patients presenting already primary or incisional hernia of the abdominal wall
  • ASA ≥IV
  • Intraoperative conversion to laparotomy
  • Emergency surgery
  • Pregnancy
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
94 participants (estimated)

Study arms

  • Experimental
    Prosthesis

    Firstly, a laparoscopic cholecystectomy is performed. After suturing the aponeurosis with a J needle and 0 Polydioxanone, a lightweight, large-pore mesh made of PVDF monofilament (polyvinylidene fluoride - DynaMesh-CICAT, FEC Textiltechnik, Germany) will be placed onlay, overlapping 2cm in all directions from the edge of the aponeurosis incision at the umbilical trocar site. The mesh will be fixed to the aponeurosis with cyanoacrylate glue (Glubran®, GEM, Viareggio, Italy).

    Procedure: Hincisional hernia prevention by onlay prosthesis trocar closure · Procedure: laparoscopic cholecystectomy · Diagnostic Test: Abdominal ultrasound

  • Active comparator
    Control

    Firstly, a laparoscopic cholecystectomy is performed. Closure of the aponeurosis will be performed by standard procedure: under direct vision, suturing the aponeurosis with a J needle and 0 Polydioxanone, with a stitch interval of ≤ 5mm.

    Procedure: laparoscopic cholecystectomy · Diagnostic Test: Abdominal ultrasound

Interventions

  • ProcedureHincisional hernia prevention by onlay prosthesis trocar closure

    Hincisional hernia prevention by onlay prosthesis trocar closure

  • Procedurelaparoscopic cholecystectomy

    Laparoscopic cholecystectomy with or without common bile duct exploration

  • Diagnostic testAbdominal ultrasound

    Ultrasound focused in abdominal wall defects on the trocar incisions, 12 months after the surgery

06

What researchers measure

Primary outcomes

  1. Incidence of incisional hernia

    The primary endpoint is the incidence of incisional hernia in the 2 groups. Because incisional hernia may occur within the first months after surgery, assessment will be carried out during scheduled clinical visits over 12 months. The presence of incisional hernia will be evaluated by physical examination and radiologically by an abdominal US scan performed at the end of follow-up (12 months after operation).

    Time frame: 12 months

Secondary outcomes

  1. Perioperative complications

    Secondary endpoints will be perioperative complications, including wound infection, haematoma, pain and reoperation.

    Time frame: 30 days

  2. Economical impact

    We will compare on one side the cost of the mesh and the glue and on the other side the costs of reoperation and hospital stay in case of appearance of incisional hernias.

    Time frame: 12 months

07

Study locations

2 of 2 sites recruiting
  • Pius, Hospital de Valls
    Valls, Tarragona 43800, Spain
    Recruiting
  • Hospital Universitari de Tarragona Joan XXIII
    Tarragona, 43005, Spain
    Recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 2, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT04699201
Lead sponsor
Hospital Universitari Joan XXIII de Tarragona.
Collaborators
Institut de Diagnostic per la Imatge, Institut Investigacio Sanitaria Pere Virgili
Responsible party
Joan Ferreres i Serafini (MD, 3rd year resident, General Surgery, Hospital Universitari Joan XXIII de Tarragona.) — Principal investigator
First posted
Jan 7, 2021
Start date
Mar 2, 2021
Primary completion
Nov 2024 (estimated)
Completion
Feb 2025 (estimated)
Last update
Oct 2, 2024

Study contacts

Joan Ferreres Serafini, MD
Contact
joanfs8@gmail.com
(+34) 657920793
Rosa Jorba Martin, MD
Contact
rjorba.hj23.ics@gencat.cat
Carles Olona Casas, MD
study director · Hospital Universitari de Tarragona

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion